This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.
Request a Quote |
Login

The Leading ADME-Tox Specialists

Our Services

ADME PK

ADME PK
Toxicology

Toxicology
In Silico

In Silico
Physicochemical Profiling

Physicochemical Profiling

Highlights

COVID-19 Statement

Read Evotec’s statement on the current
COVID-19 situation

Read more

Access our Popular
ADME-Tox Guides

Recently updated for the new FDA DDI guidance (Jan 2020)

Download

Regulatory DDI Studies

Full regulatory package of FDA, EMA and JMHLW recommended in vitro drug-drug interaction services

Learn More

Cardiac and CNS MEA

Cyprotex are world leaders in the field of microelectrode array. Learn more about our cardiac and CNS assays.

Learn More

3D Cell-based Models

Cyprotex are leading the science in the field of 3D cell-based technology. Our research has focused on the development of cardiac, liver, CNS and kidney models.

Learn More

EVOTEC - Our parent company

EVT EXECUT

EVT ExecuteServices
EVT INNOVATE

EVT InnovateR&D

Knowledge sharing

PUBLICATIONS & POSTERS

Publications & Posters
GUIDES

Guides

EventsUpcoming events

26th November 2020
31st Symposium on Medicin...
Virtual Event
19th – 21st January 2021
DMDG 2021 Joint Meeting -...
Virtual Event
14-18th March 2021
60th SOT Annual Meeting a...
Virtual Event

NewsLatest news

November 24th 2020
Evotec & Rappta Therapeutics enter discovery & development...
November 19th 2020
Evotec presents progress made in accelerating its co-owned...
November 17th 2020
Evotec & STORM Therapeutics leverage INDiGO platform to...

PublicationsLatest publications

Presentation
Are TripleTOF® systems the future for HT-ADME/toxicity screening?
Article
The evolution of strategies to minimise the risk of human drug induced liver injury (DILI) in drug discovery and development
View all events
View all news
View all publications

Contact us to discuss your ADME Tox issues or request a quote

Telephone:
North America (East Coast): +1-888-297-7683
Europe: +44 (0)1625 5051000

 

Email:
enquiries@cyprotex.com

or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

By clicking on ‘Send’ I agree that my data is being transferred and used by Cyprotex and the affiliated Evotec Group. The Evotec Group currently consists of the following companies. For further details please see our privacy policy.

If you would like to be kept informed of our latest services, new research, events and other news please tick the box below:

Close